Artificial Intelligence

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

Convr AI has launched agentic AI workflows, promising to slash underwriting times. But what does this shift to autonomous decisioning mean for the industry?

As brands like She Said Yes champion lab-grown gems, consumers are embracing a new era of ethical, affordable luxury. What does this mean for tradition?

With a $60M backing from a mystery investor, U Power plans to bring its AI-driven battery swapping tech to Southern Europe. Can it succeed?

A new partnership between Beacon Biosignals and Harmony Biosciences will use AI to objectively measure sleepiness, offering new hope for hypersomnia patients.

Annexus and Athene are embedding complex academic theories into new retirement products. But can they deliver on the promise of safer returns for investors?

AI data firm Hyperscale Data ties its fate to Bitcoin, with a treasury nearing its market value. A bold strategy or a risky gambit amid a major pivot?

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

A new Google-TotalEnergies deal in Malaysia reveals the collision of a data boom and green energy goals, a key test for the region's strategic future.

A new partnership between EcoFlow and Octopus Energy turns homes into automated power stations, slashing bills and reshaping the UK's energy grid.

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

MetaComp and Stable are building a compliant, high-speed payment network with stablecoins, aiming to disrupt the trillion-dollar cross-border market.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

Beyond a routine board re-election, Heidmar Maritime is doubling down on an AI-driven strategy to navigate the volatile tanker market. Here's what it means.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

A new report forecasts modest 2.6% growth for US construction in 2026, driven by data centers, water, and aviation, but challenged by major hurdles.

A new collaboration aims to transform market noise into actionable foresight, moving beyond simple bets to offer a unified view of the global economy.

CMS's new ACCESS model spotlights virtual care, positioning firms like FlyteHealth to lead a tech-driven transformation in managing chronic illness.